History of myocardial infarction and stroke among incident end-stage renal disease cases and population-based controls: An analysis of shared risk factors

American Journal of Kidney Diseases

Volumn 40, Issue 2, 2002, Pages 323-330

  Muntner, Paul ^a,b,c   Coresh, Josef ^a,b,c   Klag, Michael J ^a,b,c   Whelton, Paul K ^a,b,c   Perneger, Thomas V ^a,b,c  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Chronic kidney disease (CKD); End stage renal disease (ESRD); Myocardial infarction (MI); Risk factors; Stroke

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; STROKE; UNITED STATES;

EID: 0036329927     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2002.34515     Document Type: Article

References (35)

1. Cardiovascular risk factors, and comorbidity, and survival outcomes in black and white dialysis patients
2. Prevalence of nonfatal coronary heart disease among American adults
3. Diabetes as a risk factor for stroke. A population perspective
4. A review of stroke epidemiology
5. Atherogenic lipoproteins: Mediators of glomerular injury
6. Effects of dietary interventions on glomerular pathophysiology
7. Focal and segmental glomerulosclerosis: Analogies to atherosclerosis
8. Hyperlipidemia and progressive renal disease
9. Hypertension, hyperlipidemia, and renal damage
10. Myocardial infarction
11. Atherosclerotic renovascular disease
12. Clinical epidemiology of cardiovascular disease in chronic renal disease
13. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function: Results from the Hypertension Detection and Follow-Up Program
14. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency
15. Prevalence and correlates of elevated serum creatinine levels: The Framingham Heart Study
16. Screening and treatment for cardiovascular disease in patients with chronic renal disease
17. Lipids and the kidney
18. The progression of renal disease
19. Lipid abnormalities in renal disease
20. Risk of end-stage renal disease associated with alcohol consumption
21. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs
22. Race and endstage renal disease: Socioeconomic status and access to health care as mediating factors
23. End-stage renal disease attributable to diabetes mellitus
24. Effectiveness of the Waksberg telephone sampling method for the selection of population controls
25. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus
26. Dietary protein restriction and the progression of chronic renal disease: What have all of the results of the MDRD study shown?
27. Assessing the progression of renal disease in clinical studies: Effects of duration of follow-up and regression to the mean
28. Controlling the epidemic of cardiovascular disease in chronic renal disease: Where do we start?
29. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates
30. Validity of selfreported stroke: The Tromso study
31. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women
32. Understanding the lack of validity: Bias
33. Recall (report) bias and reliability in the retrospective assessment of melanoma risk